Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep.
Jaqueline Freitas MottaMarcos Roberto A FerreiraStefanie Bressan WallerRafael Rodrigues RodriguesRafael Amaral DonassoloClóvis Moreira JúniorMariliana Luiza Ferreira AlvesFernanda Dornelles FeijóFabricio Rochedo ConceiçãoPublished in: Anaerobe (2024)
While adjustments are required, the recombinant bacterin platform holds great potential for polyvalent vaccines due to its straightforward, safe, and cost-effective production, establishing it as a user-friendly technology for the veterinary immunobiological industry.